Breast cancer risk and use of calcium channel blockers using Swedish population registries

JAMA Internal Medicine

Volumn 174, Issue 10, 2014, Pages 1700-1701

  Bergman, Gudrun Jonasdottir ^a   Khan, Staffan ^a   Danielsson, Bengt ^a   Borg, Natalia ^a  

^a NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGE; AGED; BREAST CANCER; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; BREAST NEOPLASMS; CHEMICALLY INDUCED; MIDDLE AGED; REGISTER; RISK; STATISTICAL MODEL; SWEDEN;

AGED; BREAST NEOPLASMS; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; REGISTRIES; RISK; SWEDEN;

EID: 84907999060     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.3867     Document Type: Letter

References (4)

1. Anatomical therapeutic chemical classification system. World Health Organization Collaborating Centre for Drug StatisticsMethodology website. http://www.whocc.no/. Accessed August 22, 2013.
2. Li CI, Daling JR, Tang MTC, Haugen KL, Porter PL, Malone KE. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med. 2013; 173(17):1629-1637.
3. Coogan PF. Calcium-channel blockers and breast cancer: a hypothesis revived. JAMA Intern Med. 2013; 173(17):1637-1638.
4. National Board of Health andWelfare home page. Socialstyrelsen website. http://www.socialstyrelsen.se/english. Accessed March 12, 2013.